WilliamFranklinHoffmanMD
Psychiatry • Portland, ORGeriatric Psychiatry
Associate Professor, Psychiatry, Oregon Health and Science University School of Medicine
Are you Dr. Hoffman?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 20 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
3710 Sw Us Veterans Hospital Rd
Mental Health Division P35c
Portland, OR 97239Phone+1 503-273-5049
Summary
- Dr. William Hoffman, MD is a board certified psychiatrist in Portland, Oregon. He is currently licensed to practice medicine in Oregon. He is affiliated with Portland HCS and OHSU Hospital.
Education & Training
Oregon Health & Science University (OHSU Health)Residency, Psychiatry, 1981 - 1985
University of Wisconsin School of Medicine & Public HealthClass of 1981
Certifications & Licensure
OR State Medical License 1982 - 2025- American Board of Psychiatry and Neurology Psychiatry
Clinical Trials
- Neurobiology of Alcohol and Nicotine Co-Addiction Start of enrollment: 2017 Oct 01
- Pilot Study of the Effect of Ibudilast on Neuroinflammation in Methamphetamine Users Start of enrollment: 2019 May 01
Publications & Presentations
PubMed
- 153 citationsCortical activation during delay discounting in abstinent methamphetamine dependent individualsWilliam F. Hoffman, Daniel Schwartz, Marilyn Huckans, Bentson H. McFarland, Gal Meiri
Psychopharmacology. 2008-08-07 - 170 citationsThe Prevalence of Metoclopramide-Induced Tardive Dyskinesia and Acute Extrapyramidal Movement DisordersLinda Ganzini, Daniel E. Casey, William F. Hoffman, Anthony L. McCall
Archives of Internal Medicine. 1993-06-28 - 129 citationsGlobal and local morphometric differences in recently abstinent methamphetamine-dependent individuals.Daniel Schwartz, Alex Mitchell, David Lahna, Hannah S. Luber, Marilyn Huckans
Neuroimage. 2010-05-01
Press Mentions
MediciNova Announces Collaboration with the U.S. Department of Veterans Affairs and Oregon Health & Science University to Evaluate MN-166 (Ibudilast) in Methamphetamine Use DisorderNovember 9th, 2017
Depression Treatment Center OregonNovember 1st, 2017
